LogicBio Therapeutics, Inc. Interest Expense
LogicBio Therapeutics, Inc. reported Interest Expense of $176.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2022-11-14
- LogicBio Therapeutics, Inc. interest expense for the quarter ending 2022-09-30 was $176.00K, a 34.81% decline year-over-year.
- LogicBio Therapeutics, Inc. interest expense for the quarter ending 2022-06-30 was $197.00K, a 30.39% decline year-over-year.
- LogicBio Therapeutics, Inc. interest expense for the quarter ending 2022-03-31 was $218.00K, a 19.56% decline year-over-year.
- LogicBio Therapeutics, Inc. interest expense for the quarter ending 2021-12-31 was $246.00K, a 11.19% decline year-over-year.
- LogicBio Therapeutics, Inc. interest expense for fiscal 2021 was $1.07M, a 2.55% decline from fiscal 2020.
- LogicBio Therapeutics, Inc. interest expense for fiscal 2020 was $1.10M, a 101.10% increase from fiscal 2019.
- LogicBio Therapeutics, Inc. interest expense for fiscal 2019 was $546.00K, a 27200.00% increase from fiscal 2018.
- LogicBio Therapeutics, Inc. interest expense for fiscal 2018 was $2.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2022-09-30 | $176.00K 10-Q · filed 2022-11-14 | $373.00K derived: sum of 2 quarters · filed 2022-11-14 | $591.00K 10-Q · filed 2022-11-14 | $837.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | $197.00K 10-Q · filed 2022-08-15 | $415.00K 10-Q · filed 2022-08-15 | $661.00K derived: sum of 3 quarters · filed 2022-08-15 | $931.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-03-31 | $218.00K 10-Q · filed 2022-05-16 | $464.00K derived: sum of 2 quarters · filed 2022-05-16 | $734.00K derived: sum of 3 quarters · filed 2022-11-14 | $1.02M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-12-31 | $246.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $516.00K derived: sum of 2 quarters · filed 2022-11-14 | $799.00K derived: sum of 3 quarters · filed 2022-11-14 | $1.07M 10-K · filed 2022-03-04 |
| 2021-09-30 | $270.00K 10-Q · filed 2022-11-14 | $553.00K derived: sum of 2 quarters · filed 2022-11-14 | $824.00K 10-Q · filed 2022-11-14 | $1.10M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $283.00K 10-Q · filed 2022-08-15 | $554.00K 10-Q · filed 2022-08-15 | $831.00K derived: sum of 3 quarters · filed 2022-08-15 | $1.11M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $271.00K 10-Q · filed 2022-05-16 | $548.00K derived: sum of 2 quarters · filed 2022-05-16 | $824.00K derived: sum of 3 quarters · filed 2022-05-16 | $1.10M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $553.00K derived: sum of 2 quarters · filed 2022-03-04 | $826.00K derived: sum of 3 quarters · filed 2022-03-04 | $1.10M 10-K · filed 2022-03-04 |
| 2020-09-30 | $276.00K 10-Q · filed 2021-11-15 | $549.00K derived: sum of 2 quarters · filed 2021-11-15 | $821.00K 10-Q · filed 2021-11-15 | $1.10M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $273.00K 10-Q · filed 2021-08-09 | $545.00K 10-Q · filed 2021-08-09 | $820.00K derived: sum of 3 quarters · filed 2021-08-09 | $1.09M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $272.00K 10-Q · filed 2021-05-10 | $547.00K derived: sum of 2 quarters · filed 2021-05-10 | $818.00K derived: sum of 3 quarters · filed 2021-05-10 | |
| 2019-12-31 | $275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $546.00K derived: sum of 2 quarters · filed 2021-03-15 | $546.00K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $271.00K 10-Q · filed 2020-11-09 | $271.00K 10-Q · filed 2020-11-09 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $1.00K derived: sum of 2 quarters · filed 2020-03-16 | $2.00K 10-K · filed 2020-03-16 | |
| 2018-09-30 | $1.00K 10-Q · filed 2019-11-12 | $2.00K 10-Q · filed 2019-11-12 |